Summary
- The Central Drugs Standard Control Organization (CDSCO) has issued a circular warning against the indiscriminate use of NSAIDs and antibiotics, emphasizing prescription-only sales to mitigate health risks.
- The advisory highlights the connection between misuse and chronic kidney disease, urging stakeholders to adhere to the Drugs and Cosmetics Act, 1940.
- Specific recommendations target the general public, healthcare professionals, pharmacists, and state authorities to promote responsible medication practices.
- This guidance aims to combat adverse drug reactions and antimicrobial resistance, reinforcing the importance of medical supervision in drug use.
Join the discussion ā sign up to comment, upvote, and save articles.